Liver Stiffness Measurement and Risk Prediction of Hepatocellular Carcinoma After HCV Eradication in Veterans With Cirrhosis
Authors:
- 5 December 2023
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 22 (4) , 778-788.e7
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P30 CA016059)
- National Institutes of Health
This publication has 16 references indexed in Scilit:
- Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and HarmsAmerican Journal of Gastroenterology, 2020
- Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antiviralsJournal of Hepatology, 2020
- Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 ScoresGastroenterology, 2019
- Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosisPLOS ONE, 2018
- Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling ProjectBritish Journal of Cancer, 2018
- Age-specific sex difference in the incidence of hepatocellular carcinoma in the United StatesOncotarget, 2017
- Portal hypertensive bleeding in cirrhosisHepatology, 2017
- Child–Pugh Versus MELD Score for the Assessment of Prognosis in Liver CirrhosisMedicine, 2016
- Racial/Ethnic Disparities in Access to Care and Survival for Patients With Early-Stage Hepatocellular CarcinomaArchives of Surgery, 2010
- The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinomaAnnals of Oncology, 2008